Sentiment-Signal
22,5
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
63.8
1 neu, 2 erhöht, -43023521K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 30.01.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ion 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointm |
| 01.12.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n the Original 8-K otherwise remains unchanged. ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF |
| 17.11.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINT |
| 15.10.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | orth by specific reference in such filing. ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIREC |
| 27.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n 13(a) of the Exchange Act. ☐ ITEM 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINT |
| 10.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ion 13(a) of the Exchange Act. ☐ ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointm |
| 30.08.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | xchange Act. ☐ ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain |
| 27.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n 13(a) of the Exchange Act. ☐ ITEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment |
| 27.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n 13(a) of the Exchange Act. ☐ ITEM 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointmen |
| 24.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment |
| 06.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | n 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointmen |
Stammdaten
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Unternehmen & Branche
| Name | BECTON DICKINSON & CO |
|---|---|
| Ticker | BDX |
| CIK | 0000010795 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Instruments & Supplies |
| SIC | 3841 · Surgical & Medical Instruments & Apparatus |
Wertpapier & Kennzahlen
| CUSIP | 075887109 |
|---|---|
| ISIN | US0758871091 |
| Typ | Common Stock |
| Marktkapitalisierung | 57,40 Mrd. USD |
| Beta | 0,35 |
| Dividendenrendite | 3,51 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-Q | 5,252,000,000 | 382,000,000 | 1.34 | 54,841,000,000 | 25,282,000,000 |
| 2025-09-30 | 10-K | 21,840,000,000 | 1,678,000,000 | 5.82 | 55,325,000,000 | 25,390,000,000 |
| 2025-06-30 | 10-Q | 5,509,000,000 | 574,000,000 | 2.00 | 54,902,000,000 | 25,472,000,000 |
| 2025-03-31 | 10-Q | 5,272,000,000 | 308,000,000 | 1.07 | 54,467,000,000 | 25,241,000,000 |
| 2024-12-31 | 10-Q | 5,168,000,000 | 303,000,000 | 1.04 | 54,665,000,000 | 25,205,000,000 |
| 2024-09-30 | 10-K | 20,178,000,000 | 1,705,000,000 | 5.86 | 57,286,000,000 | 25,890,000,000 |
| 2024-06-30 | 10-Q | 4,990,000,000 | 487,000,000 | 1.68 | 55,582,000,000 | 25,868,000,000 |
| 2024-03-31 | 10-Q | 5,045,000,000 | 537,000,000 | 1.85 | 54,157,000,000 | 25,647,000,000 |
| 2023-12-31 | 10-Q | 4,706,000,000 | 281,000,000 | 0.96 | 52,274,000,000 | 25,332,000,000 |
| 2023-09-30 | 10-K | 19,372,000,000 | 1,484,000,000 | 4.94 | 52,780,000,000 | 25,796,000,000 |
| 2023-06-30 | 10-Q | 4,878,000,000 | 407,000,000 | 1.36 | 53,017,000,000 | 25,937,000,000 |
| 2023-03-31 | 10-Q | 4,821,000,000 | 460,000,000 | 1.53 | 54,394,000,000 | 25,689,000,000 |
| 2022-12-31 | 10-Q | 4,586,000,000 | 509,000,000 | 1.70 | 53,129,000,000 | 25,472,000,000 |
| 2022-09-30 | 10-K | 18,870,000,000 | 1,779,000,000 | 5.88 | 52,934,000,000 | 25,282,000,000 |
| 2022-06-30 | 10-Q | 4,641,000,000 | 360,000,000 | 1.18 | 53,199,000,000 | 25,493,000,000 |
| 2022-03-31 | 10-Q | 4,750,000,000 | 454,000,000 | 1.50 | 54,786,000,000 | 24,525,000,000 |
| 2021-12-31 | 10-Q | 4,718,000,000 | 677,000,000 | 2.28 | 53,363,000,000 | 24,160,000,000 |
| 2021-09-30 | 10-K | 19,131,000,000 | 2,092,000,000 | 6.85 | 53,866,000,000 | 23,677,000,000 |
| 2021-06-30 | 10-Q | 4,607,000,000 | 525,000,000 | 1.72 | 54,333,000,000 | 24,135,000,000 |
| 2021-03-31 | 10-Q | 4,907,000,000 | 299,000,000 | 0.94 | 54,921,000,000 | 24,826,000,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 36,678,939 | 0 | 36,678,939 | 7,118,281,692 | Neu | +100,0% | |
| BlackRock, Inc. | 27,648,705 | 0 | 27,648,705 | 5,365,784,238 | Neu | +100,0% | |
| STATE STREET CORP | 13,989,132 | 0 | 13,989,132 | 2,714,870,847 | Neu | +100,0% | |
| First Eagle Investment Management, LLC | 11,646,000 | 0 | 11,646,000 | 2,260,139,284 | Neu | +100,0% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 9,486,694 | 0 | 9,486,694 | 1,841,082,704 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 6,885,361 | 0 | 6,885,361 | 1,331,164,666 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 5,472,003 | 0 | 5,472,003 | 1,061,951,604 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 5,299,030 | 0 | 5,299,030 | 1,028,382,752 | Neu | +100,0% | |
| Clearbridge Investments, LLC | 4,092,337 | 0 | 4,092,337 | 794,199,928 | Neu | +100,0% | |
| Invesco Ltd. | 3,790,490 | 0 | 3,790,490 | 735,620,464 | Neu | +100,0% | |
| NORGES BANK | 3,783,792 | 0 | 3,783,792 | 734,320,513 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 3,499,218 | 0 | 3,499,218 | 679,093,485 | Neu | +100,0% | |
| MORGAN STANLEY | 3,374,640 | 0 | 3,374,640 | 654,916,597 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3,199,398 | 0 | 3,199,398 | 620,909,003 | Neu | +100,0% | |
| AMERICAN CENTURY COMPANIES INC | 3,129,651 | 0 | 3,129,651 | 607,371,852 | Neu | +100,0% | |
| Veritas Asset Management LLP | 2,874,579 | 0 | 2,874,579 | 557,869,547 | Neu | +100,0% | |
| HARRIS ASSOCIATES L P | 2,841,721 | 0 | 2,841,721 | 551,492,794 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 2,813,314 | 0 | 2,813,314 | 545,979,796 | Neu | +100,0% | |
| NORDEA INVESTMENT MANAGEMENT AB | 2,773,058 | 0 | 2,773,058 | 541,328,651 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 2,504,289 | 0 | 2,504,289 | 486,007,365 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 2,405,430 | 0 | 2,405,430 | 466,857,642 | Neu | +100,0% | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 2,384,372 | 0 | 2,384,372 | 462,896,432 | Neu | +100,0% | |
| Longview Partners (Guernsey) LTD | 2,160,601 | 0 | 2,160,601 | 419,307,836 | Neu | +100,0% | |
| First Pacific Advisors, LP | 1,951,246 | 0 | 1,951,246 | 378,678,311 | Neu | +100,0% | |
| Legal & General Group Plc | 1,930,445 | 0 | 1,930,445 | 374,641,462 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1,627,129 | 0 | 1,627,129 | 315,776,955 | Neu | +100,0% | |
| BARCLAYS PLC | 1,602,030 | 0 | 1,602,030 | 310,905,960 | Neu | +100,0% | |
| FMR LLC | 1,532,988 | 0 | 1,532,988 | 297,507,022 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,496,658 | 0 | 1,496,658 | 290,456,419 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 1,457,212 | 0 | 1,457,212 | 282,801,131 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 1,388,854 | 0 | 1,388,854 | 269,535,768 | Neu | +100,0% | |
| UBS Group AG | 1,293,352 | 0 | 1,293,352 | 251,000,823 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 1,252,270 | 0 | 1,252,270 | 243,027,992 | Neu | +100,0% | |
| BRANDES INVESTMENT PARTNERS, LP | 1,229,707 | 0 | 1,229,707 | 238,651,416 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 1,186,943 | 0 | 1,186,943 | 230,350,070 | Neu | +100,0% | |
| COOKE & BIELER LP | 1,126,471 | 0 | 1,126,471 | 218,614,227 | Neu | +100,0% | |
| FIDUCIARY MANAGEMENT INC /WI/ | 1,103,441 | 0 | 1,103,441 | 214,144,795 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 952,416 | 0 | 952,416 | 184,835,374 | Neu | +100,0% | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 951,456 | 0 | 951,456 | 184,649,066 | Neu | +100,0% | |
| HSBC HOLDINGS PLC | 940,908 | 0 | 940,908 | 183,161,363 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 902,187 | 0 | 902,187 | 175,087,431 | Neu | +100,0% | |
| ProShare Advisors LLC | 901,808 | 0 | 901,808 | 175,013,878 | Neu | +100,0% | |
| Focus Partners Wealth | 884,056 | 0 | 884,056 | 171,525,815 | Neu | +100,0% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 839,854 | 0 | 839,854 | 162,990,466 | Neu | +100,0% | |
| Swiss National Bank | 785,502 | 0 | 785,502 | 152,442,373 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 765,381 | 0 | 765,381 | 148,537,402 | Neu | +100,0% | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 735,888 | 0 | 735,888 | 142,813,784 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 715,481 | 0 | 715,481 | 138,853,398 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 644,135 | 0 | 644,135 | 125,010,000 | Neu | +100,0% | |
| DAVENPORT & Co LLC | 614,002 | 0 | 614,002 | 119,454,130 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-04-27 | Feld Michael | Officer, EVP, Chief Revenue Officer | Open Market Sale | -74 | 151.94 | -11,243.56 | -8,9% | |
| 2026-03-26 | Feld Michael | Officer, EVP, Chief Revenue Officer | Open Market Sale | -75 | 156.83 | -11,762.25 | -9,3% | |
| 2026-02-26 | Feld Michael | Officer, EVP, Chief Revenue Officer | Open Market Sale | -75 | 181.84 | -13,638.00 | -10,7% | |
| 2026-02-18 | SCOTT BERTRAM L | Director | Open Market Sale | -953 | 182.61 | -174,027.33 | -137,0% | |
| 2026-01-26 | Feld Michael | Officer, EVP, CRO & Pres. Life Sciences | Open Market Sale | -75 | 202.73 | -15,204.75 | -12,0% | |
| 2026-01-15 | Garrison Michael David | Officer, EVP & Pres Med.Essntl&BioPharm | Open Market Sale | -600 | 209.00 | -125,400.00 | -98,7% | |
| 2026-01-15 | Garrison Michael David | Officer, EVP & Pres Med.Essntl&BioPharm | Open Market Sale | -1,010 | 206.54 | -208,605.40 | -164,3% | |
| 2025-12-26 | Feld Michael | Officer, EVP, CRO & Pres. Life Sciences | Open Market Sale | -74 | 196.08 | -14,509.92 | -11,4% | |
| 2025-12-17 | Garrison Michael David | Officer, EVP & Pres Med.Essntl&BioPharm | Open Market Sale | -629 | 196.03 | -123,302.87 | -97,1% | |
| 2025-12-01 | Feld Michael | Officer, EVP, CRO & Pres. Life Sciences | Open Market Sale | -75 | 193.36 | -14,502.00 | -11,4% | |
| 2025-11-07 | SCOTT BERTRAM L | Director | Open Market Sale | -217 | 176.58 | -38,317.86 | -30,2% | |
| 2025-10-27 | Feld Michael | Officer, EVP & President, Life Sciences | Open Market Sale | -57 | 186.01 | -10,602.57 | -8,3% | |
| 2025-09-26 | Feld Michael | Officer, EVP & President, Life Sciences | Open Market Sale | -58 | 181.03 | -10,499.74 | -8,3% | |
| 2025-09-10 | Fraser Claire | Director | Open Market Sale | -917 | 187.50 | -171,937.50 | -135,4% | |
| 2025-08-22 | Feld Michael | Officer, EVP & President, Life Sciences | Open Market Sale | -57 | 197.99 | -11,285.43 | -8,9% | |
| 2025-08-11 | HAYES GREGORY | Director | Open Market Purchase | 5,250 | 191.57 | 1,005,742.50 | +792,0% | |
| 2025-08-08 | Fraser Claire | Director | Open Market Sale | -863 | 192.30 | -165,954.90 | -130,7% | |
| 2025-07-18 | Garrison Michael David | Officer, EVP & President, Medical | Open Market Sale | -1 | 181.50 | -181.50 | -0,1% | |
| 2025-07-18 | Garrison Michael David | Officer, EVP & President, Medical | Open Market Sale | -1,184 | 180.29 | -213,463.36 | -168,1% | |
| 2025-06-02 | Shan David | Officer, EVP and Chief ISC Officer | Open Market Sale | -1,166 | 171.19 | -199,607.54 | -157,2% |
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-03-27 | 83 | 157,38 | 13.063 |
| 2026-03-26 | 197 | 158,27 | 31.179 |
| 2026-03-25 | 71 | 155,92 | 11.070 |
| 2026-03-24 | 517 | 156,23 | 80.771 |
| 2026-03-23 | 2 | 154,13 | 308 |
| 2026-03-18 | 44.890 | 161,64 | 7.256.020 |
| 2026-03-09 | 477 | 167,12 | 79.716 |
| 2026-03-06 | 5.722 | 169,94 | 972.397 |
| 2026-03-05 | 426 | 171,49 | 73.055 |
| 2026-03-02 | 1.155 | 176,48 | 203.834 |
| 2026-02-24 | 255 | 184,34 | 47.007 |
| 2026-02-23 | 2.039 | 185,39 | 378.010 |
| 2026-02-20 | 1.321 | 182,47 | 241.043 |
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| AVITY INVESTMENT MANAGEMENT INC. | 188,677 | 29,665,662 | 89.75 |
| OPPENHEIMER & CO INC | 15,399 | 2,421,185 | 7.33 |
| WASHINGTON CAPITAL MANAGEMENT, INC | 6,145 | 966,178 | 2.92 |